Canaan VII

Canaan VII is an early-stage venture capital fund managed by Canaan Partners, a global firm established in 1987 and based in San Francisco, California. The fund focuses on investing in the software and technology, media, and telecommunications (TMT) sectors within the United States. Canaan Partners manages a diverse portfolio with over 190 exits and has invested in more than 250 companies across various industries, including fintech, healthcare, and digital health. The firm employs a team of experienced investment professionals who seek to support visionary entrepreneurs with innovative ideas, providing capital ranging from $1 million to $20 million across different stages of development. With approximately $5 billion under management across multiple funds, Canaan Partners continues to play a significant role in fostering growth within the technology and healthcare landscapes.

Brent Ahrens

General Partner

Brenton K. Ahrens

General Partner - West Coast

Nandu Anilal

Investor

John Balen

Partner - West Coast

Joydeep Bhattacharyya

General Partner - West Coast

Stephen Bloch

General Partner - East Coast

Laura Chau

Partner

Daniel T. Ciporin

General Partner

Colleen Cuffaro

Partner

Brendan Dickinson

General Partner

Peter Farina Ph.D

Executive in Residence - East Coast

Rayfe Gaspar-Asaoka

Partner

Julie Grant

General Partner - West Coast

Nairi Hourdajian

Vice President, Marketing and Communications

Wende Hutton

General Partner - West Coast

Maha Ibrahim

General Partner

Deepak Kamra

General Partner - West Coast

Nina Kjellson

General Partner

Ehud Levy

Co-Founder & General Partner, Canaan Partners Israel

Jared Newman

Investor

John Pacifico

General Partner, Chief Operating Officer, and Chief Financial Officer - East Coast

Hootan Rashidifard

Principal

Guy Russo

General Partner - East Coast

Timothy Shannon

General Partner - East Coast

Hrach Simonian

General Partner

Bob Williams

Venture Partner

Eric Young

Co-Founder and Partner - West Coast

Past deals in US East Coast

Lev

Series B in 2022
LEV is a tech-enabled commercial real estate broker for capital markets advisors. They use machine learning and artificial intelligence to identify the best financing scenarios and lenders for every deal, based on historical data and lender activity. The company technology quickly and automatically organizes deal- and property-related documents, while digitizing them for easier management and storage. LEV was founded in 2019 and is headquartered in New York, NY, USA.

Hermeus

Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.

Hermeus

Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.

Mantra Health

Series A in 2022
Mantra Health is a developer of a mental healthcare platform specifically designed to cater to students. The platform provides access to psychiatric care, free online assessments, and scheduled initial video consultations, allowing students to receive personalized care plans. By facilitating treatment in a comfortable and accessible manner, Mantra Health aims to enhance the mental well-being of students, making it easier for them to seek help and manage their mental health from the convenience of their homes.

Reibus

Series B in 2021
Reibus operates an independent online B2B marketplace focused on the buying and selling of prime and excess materials for industrial markets. The platform aims to enhance price performance, streamline time to market, and broaden market reach while lowering sales and marketing costs compared to traditional methods. For sellers, Reibus provides a means to efficiently list their materials, while buyers benefit from increased selection, market transparency, and a simplified procurement process. A key feature of the marketplace is its proprietary search tool, which facilitates a more efficient and user-friendly experience for both parties, expediting what is typically a cumbersome sourcing process.

nTopology

Series D in 2021
nTopology, Inc. develops engineering design software that enhances manufacturing processes. Its primary offering, nTopology, allows engineers to create lightweight and optimized parts tailored to functional requirements. The software integrates design, simulation, and advanced manufacturing into a cohesive workflow, addressing geometry bottlenecks and enhancing team collaboration. Key features include Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis. nTopology's tools enable precise control over spatial variations, facilitating a broader range of designs and effective utilization of analysis data. The company serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and based in New York, nTopology aims to redefine engineering design tools for advanced manufacturing.

TrueFort

Series B in 2021
TrueFort Fortress is a comprehensive, real-time cloud and application workload protection solution that secures the largest, most targeted and most dynamic, part of the enterprise attack surface … its application environment. It leverages telemetry from your existing agents and delivers more value than point or infrastructure-focused solutions. Best of all, it is a single console, policy, and reporting system from which to measure, control and immediately improve your risk posture.

Tropic

Series A in 2021
Tropic Technologies, Inc. is a New York-based company that offers online software selection services through a specialized martech platform. Founded in 2019, Tropic assists individuals and organizations in evaluating and procuring software by enabling them to discover software vendors and assess their offerings based on specific requirements. The platform covers various software categories, including marketing, sales, data and analytics, e-commerce, creative design, collaboration, human resources, and cybersecurity. By acting as a tech-enabled procurement service for startups, Tropic manages contracts and negotiations with vendors on behalf of its clients. This approach helps to reduce software overspending, streamline contract management, and achieve better pricing through established vendor relationships. Additionally, Tropic provides a contractual guarantee of savings, offering clients a financial safety net if their expectations are not met.

OffLimits

Seed Round in 2021
Offlimits, Inc. produces and sells breakfast products in New York. The company provides cereals, such as Zombie Vanilla & Pandan cereals and Dash Coffee & Cocoa cereals. It also sells products online. Offlimits, Inc. was incorporated in 2019 and is based in New York, New York.

Buzzer

Series A in 2021
Buzzer Media Inc. operates a mobile platform that focuses on delivering notification-driven live sports streaming. Founded in 2020 and based in New York, the company aggregates sports rights and content, providing custom notifications to enhance the viewing experience for fans. Buzzer aims to simplify the discovery of live sports moments, enabling users to seamlessly transition between different leagues and games. Through its subscription services, Buzzer caters to the personalized preferences of sports enthusiasts, facilitating immediate access to live events.

nate

Series A in 2021
NATE INC. develops artificial intelligent software to transact online on behalf of people. The company was founded in 2018 and is based in New York, New York.

Reibus

Series A in 2021
Reibus operates an independent online B2B marketplace focused on the buying and selling of prime and excess materials for industrial markets. The platform aims to enhance price performance, streamline time to market, and broaden market reach while lowering sales and marketing costs compared to traditional methods. For sellers, Reibus provides a means to efficiently list their materials, while buyers benefit from increased selection, market transparency, and a simplified procurement process. A key feature of the marketplace is its proprietary search tool, which facilitates a more efficient and user-friendly experience for both parties, expediting what is typically a cumbersome sourcing process.

JOOR

Series D in 2021
JOOR, Inc. operates an online global fashion marketplace for wholesale buying. It serves as a digital marketplace and data exchange that connects brands and retailers. JOOR, Inc. has a strategic partnership with ORDRE. The company was founded in 2010 and is based in New York, New York with additional offices in Los Angeles, California; London, United Kingdom; Milan, Italy; Paris, France; and Sydney and Melbourne, Australia.

PreShow

Seed Round in 2021
PreShow provides a concept that makes moviegoing completely free by connecting brands with moviegoers on a one-to-one basis. Its app features a new proprietary platform where consumers can earn the ability to see movies in theaters for free. The company was founded in 2019 and is headquartered in New York.

Mantra Health

Seed Round in 2021
Mantra Health is a developer of a mental healthcare platform specifically designed to cater to students. The platform provides access to psychiatric care, free online assessments, and scheduled initial video consultations, allowing students to receive personalized care plans. By facilitating treatment in a comfortable and accessible manner, Mantra Health aims to enhance the mental well-being of students, making it easier for them to seek help and manage their mental health from the convenience of their homes.

Lev

Seed Round in 2021
LEV is a tech-enabled commercial real estate broker for capital markets advisors. They use machine learning and artificial intelligence to identify the best financing scenarios and lenders for every deal, based on historical data and lender activity. The company technology quickly and automatically organizes deal- and property-related documents, while digitizing them for easier management and storage. LEV was founded in 2019 and is headquartered in New York, NY, USA.

Stargazer Pharmaceuticals

Series A in 2020
Stargazer Pharmaceuticals Inc. is a biopharmaceutical company based in Boston, Massachusetts, founded in 2018. The company specializes in developing and manufacturing therapies for rare eye diseases, with a particular focus on Stargardt’s disease, a form of juvenile retinal degeneration. Currently operating in stealth mode, Stargazer Pharmaceuticals aims to provide novel treatment options for conditions that lack existing therapies, thus enabling healthcare professionals to better address the needs of patients with these rare diseases.

Hermeus

Series A in 2020
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.

nTopology

Series C in 2020
nTopology, Inc. develops engineering design software that enhances manufacturing processes. Its primary offering, nTopology, allows engineers to create lightweight and optimized parts tailored to functional requirements. The software integrates design, simulation, and advanced manufacturing into a cohesive workflow, addressing geometry bottlenecks and enhancing team collaboration. Key features include Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis. nTopology's tools enable precise control over spatial variations, facilitating a broader range of designs and effective utilization of analysis data. The company serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and based in New York, nTopology aims to redefine engineering design tools for advanced manufacturing.

Nguyen Coffee Supply

Pre Seed Round in 2020
Nguyen Coffee Supply is a Vietnamese-American-owned business based in Brooklyn, New York, specializing in the import, sourcing, and roasting of green coffee beans from Vietnam. Established in 2018, the company operates an online platform that retails its unique Vietnamese coffees, catering to a growing market interested in diverse coffee flavors and origins. By focusing on high-quality beans and traditional roasting methods, Nguyen Coffee Supply aims to promote and celebrate Vietnamese coffee culture while providing consumers with authentic coffee experiences.

nate

Seed Round in 2020
NATE INC. develops artificial intelligent software to transact online on behalf of people. The company was founded in 2018 and is based in New York, New York.

Alkymi

Seed Round in 2020
Alkymi, Inc. is a New York-based company that specializes in developing a data inbox designed for enterprises to manage unstructured data effectively. Founded in 2017, Alkymi's platform automates the extraction and normalization of data from various sources, including emails, documents, PDFs, images, and XML, enabling organizations to make real-time decisions and take action. By leveraging advanced machine learning and automation technologies, Alkymi streamlines the data processing workflow, allowing users in sectors such as financial services, operations, compliance, and sales to handle large volumes of unstructured data with ease. This innovation helps eliminate the complexities associated with data management, ultimately enhancing productivity and decision-making capabilities within enterprises.

Bravo Sierra

Series A in 2020
Bravo Sierra is the first military-native performance wellness company, pioneering a user-driven performance personal care and nutrition organization developed within the U.S. military community. Powered by the insight generated through social manufacturing including direct collaboration with its core community of 1,000 U.S. military active duty service members, the company delivers performance goods with unprecedented responsiveness and accuracy for those who serve and for the benefit of all. Designed to support and enhance today's ultra-active lifestyle and engineered with critically relevant innovation and stress-tested in the field, the products include first-to-market technologies and formulas that are clean, vegan, and cruelty-free. Bravo Sierra is built around a revenue share model contributing 5% of all sales to the Morale Welfare and Recreation (MWR) program, which offers a complete range of community support and quality of life programs for members of the U.S. Armed Forces, their families, retirees, and veterans.

Homeis

Series A in 2019
Homeis Inc. operates an online social network designed to connect local foreign-born communities. Founded in 2016 and based in New York, the platform enables users to share their culture, local knowledge, and experiences, fostering a sense of belonging among diverse groups. Homeis provides both Android and iOS applications, facilitating easy access to its services. The company's mission is to empower foreign-born individuals by transforming their unique perspectives and challenges into vibrant, visible communities. By leveraging technology and innovation, Homeis aims to support these communities, which play a significant role in the lives of their members, through shared insights and mutual support. Since launching its first community in December 2017, Homeis has been focused on expanding its offerings to include more communities, reflecting its commitment to inclusivity and connection for those who navigate the complexities of living in a new country while maintaining ties to their cultural roots.

Bravo Sierra

Seed Round in 2019
Bravo Sierra is the first military-native performance wellness company, pioneering a user-driven performance personal care and nutrition organization developed within the U.S. military community. Powered by the insight generated through social manufacturing including direct collaboration with its core community of 1,000 U.S. military active duty service members, the company delivers performance goods with unprecedented responsiveness and accuracy for those who serve and for the benefit of all. Designed to support and enhance today's ultra-active lifestyle and engineered with critically relevant innovation and stress-tested in the field, the products include first-to-market technologies and formulas that are clean, vegan, and cruelty-free. Bravo Sierra is built around a revenue share model contributing 5% of all sales to the Morale Welfare and Recreation (MWR) program, which offers a complete range of community support and quality of life programs for members of the U.S. Armed Forces, their families, retirees, and veterans.

nTopology

Series B in 2019
nTopology, Inc. develops engineering design software that enhances manufacturing processes. Its primary offering, nTopology, allows engineers to create lightweight and optimized parts tailored to functional requirements. The software integrates design, simulation, and advanced manufacturing into a cohesive workflow, addressing geometry bottlenecks and enhancing team collaboration. Key features include Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis. nTopology's tools enable precise control over spatial variations, facilitating a broader range of designs and effective utilization of analysis data. The company serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and based in New York, nTopology aims to redefine engineering design tools for advanced manufacturing.

Comet Therapeutics

Series A in 2019
Comet Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company focuses on developing novel small-molecule therapies aimed at treating orphan neurological disorders through its Coenzyme metabolism platform. By targeting dysregulated Coenzyme A metabolism, Comet Therapeutics seeks to address significant unmet medical needs in the field of neurology, providing potential treatments for conditions that currently lack effective options.

Kin Euphorics

Venture Round in 2019
Kin Euphorics is a New York-based company, founded in 2017, that specializes in non-alcoholic beverages designed to enhance social experiences. The company's offerings include ready-to-drink tonics made from a combination of nootropics, adaptogens, and botanicals. These functional beverages aim to promote a sense of focused relaxation, helping consumers unwind without inducing sleepiness or compromising cognitive function. Kin Euphorics targets individuals seeking a balanced and nourishing alternative to traditional alcoholic drinks, allowing them to enjoy social interactions while supporting their mental well-being.

Nocion Therapeutics

Series A in 2019
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.

Roman

Series B in 2019
Roman Health Medical LLC operates Roman, a platform for adult men who are experiencing erectile dysfunction and prefer to receive treatment online. The company was incorporated in 2017 and is headquartered in New York, New York.

Players' Lounge

Seed Round in 2019
Players' Lounge Inc., also known as Players' Lounge Online, is an online platform that enables gamers to compete for cash and prizes through e-sports competitions. Founded in 2014 and headquartered in New York, the company caters primarily to casual gamers by allowing them to find opponents willing to wager on their favorite video games or participate in tournaments. Players' Lounge aims to provide a gaming experience that offers financial opportunities to the vast majority of gamers, as opposed to just the small percentage of professional players who earn substantial incomes. By facilitating social gaming tournaments that can be played both in-person and online, Players' Lounge fosters a competitive but accessible environment for gamers looking to enhance their gaming experience while potentially earning rewards.

Tia

Seed Round in 2019
At Tia, we believe that the healthcare system was not built with women in mind. Today, considering that women control 80% of healthcare dollars in the U.S., Tia is seizing the opportunity to build a new, distinctly female model of care digitally and physically. Tia is backed by leading healthcare and consumer funds, including Torch Capital, Define Ventures, Homebrew, Threshold Ventures, and Acme Ventures.

JOOR

Series C in 2019
JOOR, Inc. operates an online global fashion marketplace for wholesale buying. It serves as a digital marketplace and data exchange that connects brands and retailers. JOOR, Inc. has a strategic partnership with ORDRE. The company was founded in 2010 and is based in New York, New York with additional offices in Los Angeles, California; London, United Kingdom; Milan, Italy; Paris, France; and Sydney and Melbourne, Australia.

Halda Therapeutics

Series A in 2019
Halda Therapeutics is a research-stage drug discovery company, seeking to create the next generation of precision medicine based on a novel therapeutic modality which may be a platform for a number of disease states.

The Inside

Seed Round in 2018
The Inside is a home furnishings brand that unlocks your shortcut to a chic home, for every style and budget. We believe in the joy of decorating, and that creating the home of your dreams — and having a great time doing it — should be an accessible experience to everyone, not just a few. Our mission is to make furniture fun, with access to more design for more value. With a revolutionary and sustainable supply chain fueled by digital printing and made-to-order manufacturing, The Inside celebrates a wide range of colors, textures, and patterns — offering custom furniture for a cookie cutter price.

Kin Euphorics

Seed Round in 2018
Kin Euphorics is a New York-based company, founded in 2017, that specializes in non-alcoholic beverages designed to enhance social experiences. The company's offerings include ready-to-drink tonics made from a combination of nootropics, adaptogens, and botanicals. These functional beverages aim to promote a sense of focused relaxation, helping consumers unwind without inducing sleepiness or compromising cognitive function. Kin Euphorics targets individuals seeking a balanced and nourishing alternative to traditional alcoholic drinks, allowing them to enjoy social interactions while supporting their mental well-being.

Rallybio

Series A in 2018
Rallybio, LLC is a biopharmaceutical company based in New Haven, Connecticut, that focuses on developing innovative therapies for patients with severe and rare disorders. Founded in 2018, the company is dedicated to addressing life-threatening conditions, particularly through its lead product candidate, RLYB211, which aims to prevent fetal and neonatal alloimmune thrombocytopenia (FNAIT). This rare disease can lead to uncontrolled bleeding in fetuses and newborns. Rallybio's research emphasizes the development of antibody, small molecule, and engineered protein therapies, primarily in the late discovery to early clinical stages. Through its efforts, Rallybio seeks to transform the lives of patients suffering from devastating diseases.

Rocketrip

Series C in 2018
Rocketrip rewards employees for making flexible, cost-saving decisions when they travel for business while providing real-time insights into travel expenses — all with no disruption to your online booking process. A custom-calibrated Price to Beat and fully managed rewards store incentivize employees to choose lower-cost travel options. Rocketrip is trusted by enterprise brands like iHeartMedia, Feld Entertainment, and Twitter. It was founded in 2013 and headquartered in New York, United States.

Arvinas

Series C in 2018
Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. The company was founded in 2013 and is headquartered in Connecticut, United States.

Liquidia Technologies

Series D in 2018
Liquidia Technologies is a late-stage clinical biopharmaceutical company based in Morrisville, North Carolina, that specializes in the development and commercialization of human therapeutics. The company utilizes its proprietary PRINT technology, a particle engineering platform that allows for the precise production of uniform drug particles, aimed at improving the safety, efficacy, and performance of various therapies. Liquidia is currently advancing two key product candidates: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for addressing local post-operative pain. In addition to its internal pipeline, Liquidia collaborates with leading pharmaceutical companies to leverage its PRINT technology across multiple therapeutic areas and drug types. The company also offers strategy and commercialization services for rare disease pharmaceutical products, including a generic formulation of treprostinil for pulmonary arterial hypertension. Founded in 2004, Liquidia Technologies continues to focus on transforming patient care through innovative therapeutic solutions.

Brigit

Venture Round in 2018
Brigit is a financial health app helping everyday Americans relieve stress today, start saving for tomorrow and permanently transform their financial futures by getting them on the path the better financial wellness. Founded in 2017, the company is headquartered in New York, New York, United States.

Homeis

Seed Round in 2017
Homeis Inc. operates an online social network designed to connect local foreign-born communities. Founded in 2016 and based in New York, the platform enables users to share their culture, local knowledge, and experiences, fostering a sense of belonging among diverse groups. Homeis provides both Android and iOS applications, facilitating easy access to its services. The company's mission is to empower foreign-born individuals by transforming their unique perspectives and challenges into vibrant, visible communities. By leveraging technology and innovation, Homeis aims to support these communities, which play a significant role in the lives of their members, through shared insights and mutual support. Since launching its first community in December 2017, Homeis has been focused on expanding its offerings to include more communities, reflecting its commitment to inclusivity and connection for those who navigate the complexities of living in a new country while maintaining ties to their cultural roots.

Ephemeral Tattoos

Seed Round in 2017
Ephemeral Solutions, Inc. operates tattoo shops. It applies ephemeral inks that have a shorter lifespan. The company was founded in 2014 and is headquartered in New York, New York.

Tomorrow.io

Series A in 2017
ClimaCell is an all-in-one weather intelligence platform that predicts and automates weather challenges. It combines Weather-of-Things data - from cell tower transmissions to connected cars - with traditional data sources and analyzes it using proprietary, cutting edge models.

Quantum Circuits

Series A in 2017
Quantum Circuits, Inc., founded in 2015 and based in New Haven, Connecticut, specializes in the development, manufacturing, and sale of quantum computers utilizing superconducting devices. The company's primary objective is to create practical and useful quantum computers, while also commercializing components, devices, and software that support fundamental research and the scaling of quantum computing. Quantum Circuits focuses on the quantum circuit model, which facilitates universal and fault-tolerant operations through error correction. The technology employs superconducting Josephson junctions that function as solid-state quantum bits, or qubits. Founded by leading experts from Yale University's Department of Applied Physics, Quantum Circuits has made significant advancements in quantum devices and information processing, contributing to notable scientific achievements, including the development of a quantum bus for entangling qubits and the execution of quantum algorithms using solid-state devices.

ExecThread

Venture Round in 2017
ExecThread is the world's largest network of executive-level talent with over 40,000 high-caliber members, whose collective influence is shaping the future of industry. We help hiring companies & recruiters connect with diverse, dynamic leaders; and we help talented exec-level professionals find their dream jobs. By empowering our member community of underrepresented leaders and allies with access to thousands of confidential executive-level jobs and board of director opportunities, ExecThread is upending the traditional practices of executive search and replacing it with a far more transparent, open and inviting process.

Truveris

Series D in 2017
Truveris, Inc. is a health information technology company based in New York that focuses on the management of pharmacy benefits and prescription drug costs. Founded in 2009, the company offers a comprehensive platform that includes solutions such as RxChoice, TruBid, and RxDash, which cater to various stakeholders in the prescription drug ecosystem, including pharmaceutical manufacturers, pharmacy benefit managers, and payers. Truveris leverages data-driven innovations to provide actionable insights that help clients navigate the complexities of pharmacy spending, ensure regulatory compliance, and validate claim payment accuracy. By offering tools for managing the entire pharmacy benefits lifecycle—from request for proposal to bill review—Truveris aims to enhance transparency and efficiency in the prescription drug market. The company's backing from multiple venture capital firms underscores its commitment to addressing rising costs and improving access to prescription medications.

Ollie

Series A in 2017
Ollie Pets, Inc. engages in preparing and delivering dog food. It offers fresh meals, beef, chicken, turkey, and various recipes. Ollie Pets, Inc. was formerly known as Earnest Food Inc. Ollie Pets, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Cardlytics

Series G in 2017
Cardlytics uses purchase-based intelligence to make marketing more relevant and measurable. They partner with more than 1,500 financial institutions – including Bank of America and PNC – to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, they have a secure view into where and when consumers are spending their money. They use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, Chicago and San Francisco.

Arrakis Therapeutics

Series A in 2017
Arrakis Therapeutics is a biopharmaceutical company focused on developing innovative drugs that target ribonucleic acid (RNA) to treat a variety of diseases, including cancer and rare genetic disorders. The company employs a unique drug discovery platform that integrates advanced RNA bioinformatics and structural tools, allowing it to identify new RNA targets and create RNA-targeted small molecules (rSMs). Its proprietary pipeline consists of these rSMs aimed at genetically validated targets across multiple disease areas. Additionally, Arrakis offers SHAPEware, a software tool that assists in predicting RNA secondary structures and potential ligand-binding sites. Founded in 2015 and based in Waltham, Massachusetts, Arrakis Therapeutics aims to enhance therapeutic options for patients through its cutting-edge research and development efforts.

Abyrx

Venture Round in 2016
Abyrx, Inc. is a company that develops, manufactures, and distributes therapeutic devices specifically designed for surgical procedures. Founded in 2013 and based in Irvington, New York, Abyrx offers a range of products, including resorbable hemostatic bone putties and applicator devices. These innovative solutions are aimed at addressing bone bleeding and facilitating bone healing by adhering to bleeding surfaces. The company’s technology also enables the delivery of drugs directly to the bone, enhancing recovery processes in various surgical fields, including orthopedic, cranial, maxillofacial, trauma, cardiothoracic, and spine surgeries. Abyrx has expanded its portfolio through acquisitions, including the HEMASORB Resorbable Hemostatic Bone Putty and the rights to develop advanced polymer technology for bone applications.

Annum Health

Seed Round in 2016
Annum Health delivers the modern alternative to traditional rehab for heavy drinking. Co-founded by proven leaders in health care, technology and alcohol treatment, Annum transforms the treatment experience while eliminating profound barriers to care — high cost, personal and professional disruption, and stigma. At a fraction of the price of inpatient care at a traditional rehab facility, Annum’s tech-enabled solution fully integrates therapy, coaching, medication and support over the course of up to a year to help people reach their individual goals.

Emissary

Series A in 2016
Emissary, Inc. provides an online platform to share advice, make introductions, and get compensated for the efforts. It provides tools to promote the businesses. The company was formerly known as Leroy Technologies, Inc. and changed its name to Emissary, Inc. in February 2017. The company was incorporated in 2012 and is headquartered in the New York, New York.

Ollie

Seed Round in 2016
Ollie Pets, Inc. engages in preparing and delivering dog food. It offers fresh meals, beef, chicken, turkey, and various recipes. Ollie Pets, Inc. was formerly known as Earnest Food Inc. Ollie Pets, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Arbor

Series A in 2016
Arbor (formerly known as Pippio) operates the first marketplace for people-based data. Publishers and app developers are empowered to surface, value, and fully monetize their data asset in a privacy-friendly, transparent manner. Marketers gain accurate insights on their customers and the tools to reach them more precisely. Founded in 2014, Arbor is headquartered in New York City with offices in San Francisco. We’re backed by First Round, Canaan Partners, and Great Oaks.

Sample6

Series C in 2016
Sample6 is a biotechnology company that specializes in the development of a synthetic-biology based diagnostic system for bacteria. Its innovative technology enables enrichment-free detection of harmful bacteria, identifying levels as low as 1 CFU/ml within just four hours. The proprietary Bioillumination Platform, created by a team of researchers including Professor Tim Lu from MIT, allows for the engineering of bioparticles that target specific unwanted bacteria, illuminating them for detection. This system is coupled with sensitive sensor technology that provides rapid on-site results without the need for a laboratory. Sample6 aims to enhance public health and safety by enabling quick and efficient detection of harmful bacteria across various industries, including food production, retail, and healthcare, addressing environments where humans and bacteria interact.

Rocketrip

Series B in 2016
Rocketrip rewards employees for making flexible, cost-saving decisions when they travel for business while providing real-time insights into travel expenses — all with no disruption to your online booking process. A custom-calibrated Price to Beat and fully managed rewards store incentivize employees to choose lower-cost travel options. Rocketrip is trusted by enterprise brands like iHeartMedia, Feld Entertainment, and Twitter. It was founded in 2013 and headquartered in New York, United States.

MightyTV

Seed Round in 2016
Discover and stream the best of movies and TV with a few easy swipes. MightyTV factors in your personal preferences along with the opinions of trusted friends so you spend less time searching, and more time streaming video you’ll love. We employ A.I. to create truly personalized experiences for our users. Choose from a wide variety of streaming services and sort by price. We keep your needs in mind with every swipe. MightyTV launched in April 2016 and is headquartered in New York City.

Ambra Health

Venture Round in 2016
Ambra Health is a medical data and image management software-as-a-service company that provides a cloud-based platform for healthcare providers. The platform is designed to enhance imaging innovation and improve collaborative care workflows by offering secure and easy access to medical images. It serves a diverse clientele, including major health systems and radiology practices, enabling them to streamline their operations and enhance patient care. Ambra Health's solutions focus on agility, interoperability, and user-friendly design, allowing organizations to adopt and integrate the technology effectively while improving business outcomes. The company aims to meet the evolving needs of the healthcare industry by delivering innovative medical image management solutions.

Direct Match

Series A in 2016
Direct Match Holdings Inc., a FINRA registered broker-dealer, offers central limit order book (CLOB) in the U.S. Treasury market. It offers CLOB for cash the U.S. Treasuries to provide a centralized platform for government debt trading. It provides trading in a CLOB for the U.S. Treasury notes and bonds. The company was incorporated in 2014 and is based in New York, New York.

NextCure

Series A in 2016
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, dedicated to discovering and developing innovative immunomedicines for cancer and other immune-related diseases. The company’s lead product candidate, NC318, is currently undergoing Phase 2 clinical trials aimed at treating advanced or metastatic solid tumors. Additionally, NextCure is advancing NC410, an immunomedicine designed to counteract immune suppression through targeting an immune modulator known as Leukocyte-Associated Immunoglobulin-like Receptor 1. The company is also engaged in research programs evaluating novel immunomodulatory molecules, including antibodies in preclinical development that target specific immune modulators in inflamed tissues and tumor microenvironments. NextCure has established a license agreement with Yale University and collaborates with Eli Lilly and Company for research and development efforts. Founded in 2015, the company leverages proprietary platforms to identify biologically relevant targets and develop first-in-class immunotherapy products.

Arvinas

Series B in 2015
Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. The company was founded in 2013 and is headquartered in Connecticut, United States.

Spyryx Biosciences

Series A in 2015
Spyryx Biosciences is a biopharmaceutical company based in Durham, North Carolina, specializing in the development of inhaled peptide therapeutics aimed at treating obstructive lung diseases, specifically cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Founded in 2013 by Dr. Robert Tarran, the company emerged from his discovery of a novel mechanism by which the lungs regulate surface fluid. This mechanism is impaired in CF patients due to genetic mutations, leading to dehydration, mucus buildup, and subsequent lung damage. Spyryx's therapeutic approach targets this underlying dysfunction, showing promising results in preclinical studies by significantly improving survival in animal models of CF. Importantly, the treatment is designed to function independently of the specific genetic mutations responsible for CF, offering potential benefits to a broader patient population. Additionally, the company is exploring the relevance of this fluid regulation mechanism in COPD, a condition characterized by chronic bronchitis and emphysema, as part of its commitment to addressing multiple obstructive lung diseases.

Ambra Health

Venture Round in 2014
Ambra Health is a medical data and image management software-as-a-service company that provides a cloud-based platform for healthcare providers. The platform is designed to enhance imaging innovation and improve collaborative care workflows by offering secure and easy access to medical images. It serves a diverse clientele, including major health systems and radiology practices, enabling them to streamline their operations and enhance patient care. Ambra Health's solutions focus on agility, interoperability, and user-friendly design, allowing organizations to adopt and integrate the technology effectively while improving business outcomes. The company aims to meet the evolving needs of the healthcare industry by delivering innovative medical image management solutions.

Rocketrip

Series A in 2014
Rocketrip rewards employees for making flexible, cost-saving decisions when they travel for business while providing real-time insights into travel expenses — all with no disruption to your online booking process. A custom-calibrated Price to Beat and fully managed rewards store incentivize employees to choose lower-cost travel options. Rocketrip is trusted by enterprise brands like iHeartMedia, Feld Entertainment, and Twitter. It was founded in 2013 and headquartered in New York, United States.

Truveris

Series C in 2014
Truveris, Inc. is a health information technology company based in New York that focuses on the management of pharmacy benefits and prescription drug costs. Founded in 2009, the company offers a comprehensive platform that includes solutions such as RxChoice, TruBid, and RxDash, which cater to various stakeholders in the prescription drug ecosystem, including pharmaceutical manufacturers, pharmacy benefit managers, and payers. Truveris leverages data-driven innovations to provide actionable insights that help clients navigate the complexities of pharmacy spending, ensure regulatory compliance, and validate claim payment accuracy. By offering tools for managing the entire pharmacy benefits lifecycle—from request for proposal to bill review—Truveris aims to enhance transparency and efficiency in the prescription drug market. The company's backing from multiple venture capital firms underscores its commitment to addressing rising costs and improving access to prescription medications.

Rocketrip

Series A in 2014
Rocketrip rewards employees for making flexible, cost-saving decisions when they travel for business while providing real-time insights into travel expenses — all with no disruption to your online booking process. A custom-calibrated Price to Beat and fully managed rewards store incentivize employees to choose lower-cost travel options. Rocketrip is trusted by enterprise brands like iHeartMedia, Feld Entertainment, and Twitter. It was founded in 2013 and headquartered in New York, United States.

Emissary

Seed Round in 2013
Emissary, Inc. provides an online platform to share advice, make introductions, and get compensated for the efforts. It provides tools to promote the businesses. The company was formerly known as Leroy Technologies, Inc. and changed its name to Emissary, Inc. in February 2017. The company was incorporated in 2012 and is headquartered in the New York, New York.

Sample6

Series B in 2013
Sample6 is a biotechnology company that specializes in the development of a synthetic-biology based diagnostic system for bacteria. Its innovative technology enables enrichment-free detection of harmful bacteria, identifying levels as low as 1 CFU/ml within just four hours. The proprietary Bioillumination Platform, created by a team of researchers including Professor Tim Lu from MIT, allows for the engineering of bioparticles that target specific unwanted bacteria, illuminating them for detection. This system is coupled with sensitive sensor technology that provides rapid on-site results without the need for a laboratory. Sample6 aims to enhance public health and safety by enabling quick and efficient detection of harmful bacteria across various industries, including food production, retail, and healthcare, addressing environments where humans and bacteria interact.

Arvinas

Series A in 2013
Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. The company was founded in 2013 and is headquartered in Connecticut, United States.

JOOR

Series B in 2013
JOOR, Inc. operates an online global fashion marketplace for wholesale buying. It serves as a digital marketplace and data exchange that connects brands and retailers. JOOR, Inc. has a strategic partnership with ORDRE. The company was founded in 2010 and is based in New York, New York with additional offices in Los Angeles, California; London, United Kingdom; Milan, Italy; Paris, France; and Sydney and Melbourne, Australia.

Artspace

Series B in 2013
Artspace is the premier online retailer where collectors can purchase works by top contemporary artists directly from leading commercial galleries, prestigious cultural institutions, and non-profits. Our curators also commission works directly from the most renowned artists working today, working closely with their studios to produce exclusive limited editions. Our mission is to help both aspiring and experienced collectors discover, learn about, and acquire art while helping artists and the institutions that support them reach broader audiences worldwide. Proceeds from many of the works on our site benefit these esteemed institutions and artists.

Marinus Pharmaceuticals

Series C in 2013
Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings. The company was founded in 2003 and is based in Branford, Connecticut.

Gemvara

Series D in 2012
Gemvara, Inc. manufactures and sells custom-made fine jewelry for women and men through an online store. Its product categories include gemstone and diamond engagement rings; wedding rings and jewelry; and created rings, necklaces, and diamond studs. Gemvara, Inc. was formerly known as Paragon Lake, Inc. and changed its name to Gemvara, Inc. in February 2010. The company was founded in 2006 and is based in Boston, Massachusetts. As of April 27, 2016, Gemvara, Inc. operates as a subsidiary of Richline Group, Inc.

Ambra Health

Series B in 2012
Ambra Health is a medical data and image management software-as-a-service company that provides a cloud-based platform for healthcare providers. The platform is designed to enhance imaging innovation and improve collaborative care workflows by offering secure and easy access to medical images. It serves a diverse clientele, including major health systems and radiology practices, enabling them to streamline their operations and enhance patient care. Ambra Health's solutions focus on agility, interoperability, and user-friendly design, allowing organizations to adopt and integrate the technology effectively while improving business outcomes. The company aims to meet the evolving needs of the healthcare industry by delivering innovative medical image management solutions.

Blip

Debt Financing in 2012
Blip is an online media platform that offers users access to a variety of video clips and programs focused on media and entertainment. The platform features content across multiple categories, including general entertainment, comedy, music, drama, television, food, and video games. It organizes its offerings into segments such as editors' picks, current trends, and new episodes. Additionally, Blip provides producers with tools to host, distribute, and monetize their web series. Founded in 2005 by Charles Hope and Jared Klett, Blip is headquartered in New York City.

Blip

Series D in 2011
Blip is an online media platform that offers users access to a variety of video clips and programs focused on media and entertainment. The platform features content across multiple categories, including general entertainment, comedy, music, drama, television, food, and video games. It organizes its offerings into segments such as editors' picks, current trends, and new episodes. Additionally, Blip provides producers with tools to host, distribute, and monetize their web series. Founded in 2005 by Charles Hope and Jared Klett, Blip is headquartered in New York City.

OpenSky

Series C in 2011
OpenSky OpenSky is a social platform that makes commerce more instant, open and connected. Founded by [John Caplan](http://www.crunchbase.com/person/john-caplan) and [Kevin Ambrosini](http://www.crunchbase.com/person/kevin-ambrosini-2), OpenSky has been named one of The World’s 50 Most Innovative Companies (alongside Apple, Facebook, Google, Amazon, Twitter, Square, Airbnb, Dropbox and Kickstarter) by Fast Company and one of America's Most Promising Companies by Forbes.

Tremor Video - Software Platform

Venture Round in 2011
Provides video advertising solutions for advertisers and agencies, and publisher partners in the United States and internationally.

Chimerix

Series F in 2011
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, dedicated to developing innovative antiviral therapeutics for patients with serious diseases, including cancer and those undergoing transplant procedures. The company’s lead candidate, CMX001, targets life-threatening double-stranded DNA viral infections and has demonstrated antiviral activity in clinical studies involving immunocompromised patients. Ongoing research includes a Phase 2 study for preventing cytomegalovirus in stem cell transplant recipients and other studies addressing adenovirus and various herpes viruses. Chimerix is also developing CMX157, a nucleoside analogue aimed at treating HIV and hepatitis B, which has shown promising results in early trials. Additionally, the company is working on dociparstat sodium, a compound intended to inhibit key proteins linked to acute myeloid leukemia, and brincidofovir, an antiviral candidate for smallpox. Chimerix holds various licensing agreements to advance its research and has received substantial federal funding to support its initiatives in public health and medical countermeasures.

Spine Wave

Series E in 2011
Spine Wave, Inc. manufactures and markets medical equipment for the treatment of spinal disorders. It offers expandable PEEK spacers and expandable interbody devices for posterior surgery; pivoting spacer systems; lateral spacer systems, XDL expandable devices, and lateral access systems for lateral stabilization; Leva PX, an expandable interbody device for the treatment of spinal disorders; GraftMag Graft Delivery System to deliver large amounts of bone graft; and fixation products, such as spine systems for treating degeneration, deformity, tumor, and trauma of the thoracolumbar spine, as well as adjacent level systems. The company also offers anterior cervical plate systems that provide stabilization as an adjunct to spinal fusion from C2-C7 through anterior screw fixation; and cervical spacer systems to treat degenerative disc disease from C2-T1. It offers its products through distributors. Spine Wave, Inc. was founded in 2001 and is based in Shelton, Connecticut.

Helix Therapeutics

Series A in 2010
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis.

Ambra Health

Series A in 2010
Ambra Health is a medical data and image management software-as-a-service company that provides a cloud-based platform for healthcare providers. The platform is designed to enhance imaging innovation and improve collaborative care workflows by offering secure and easy access to medical images. It serves a diverse clientele, including major health systems and radiology practices, enabling them to streamline their operations and enhance patient care. Ambra Health's solutions focus on agility, interoperability, and user-friendly design, allowing organizations to adopt and integrate the technology effectively while improving business outcomes. The company aims to meet the evolving needs of the healthcare industry by delivering innovative medical image management solutions.

SkillSlate

Seed Round in 2010
Skillslate enables consumers to find and connect with local individual businesses. Business owners get free marketing tools and leads to gain more customers.

Tobira Therapeutics

Series B in 2010
Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.

Cardlytics

Series C in 2010
Cardlytics uses purchase-based intelligence to make marketing more relevant and measurable. They partner with more than 1,500 financial institutions – including Bank of America and PNC – to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, they have a secure view into where and when consumers are spending their money. They use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, Chicago and San Francisco.

Liquidia Technologies

Series C in 2010
Liquidia Technologies is a late-stage clinical biopharmaceutical company based in Morrisville, North Carolina, that specializes in the development and commercialization of human therapeutics. The company utilizes its proprietary PRINT technology, a particle engineering platform that allows for the precise production of uniform drug particles, aimed at improving the safety, efficacy, and performance of various therapies. Liquidia is currently advancing two key product candidates: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for addressing local post-operative pain. In addition to its internal pipeline, Liquidia collaborates with leading pharmaceutical companies to leverage its PRINT technology across multiple therapeutic areas and drug types. The company also offers strategy and commercialization services for rare disease pharmaceutical products, including a generic formulation of treprostinil for pulmonary arterial hypertension. Founded in 2004, Liquidia Technologies continues to focus on transforming patient care through innovative therapeutic solutions.

Blip

Series C in 2010
Blip is an online media platform that offers users access to a variety of video clips and programs focused on media and entertainment. The platform features content across multiple categories, including general entertainment, comedy, music, drama, television, food, and video games. It organizes its offerings into segments such as editors' picks, current trends, and new episodes. Additionally, Blip provides producers with tools to host, distribute, and monetize their web series. Founded in 2005 by Charles Hope and Jared Klett, Blip is headquartered in New York City.
Provides video advertising solutions for advertisers and agencies, and publisher partners in the United States and internationally.

OpenSky

Series B in 2010
OpenSky OpenSky is a social platform that makes commerce more instant, open and connected. Founded by [John Caplan](http://www.crunchbase.com/person/john-caplan) and [Kevin Ambrosini](http://www.crunchbase.com/person/kevin-ambrosini-2), OpenSky has been named one of The World’s 50 Most Innovative Companies (alongside Apple, Facebook, Google, Amazon, Twitter, Square, Airbnb, Dropbox and Kickstarter) by Fast Company and one of America's Most Promising Companies by Forbes.

Gemvara

Series B in 2010
Gemvara, Inc. manufactures and sells custom-made fine jewelry for women and men through an online store. Its product categories include gemstone and diamond engagement rings; wedding rings and jewelry; and created rings, necklaces, and diamond studs. Gemvara, Inc. was formerly known as Paragon Lake, Inc. and changed its name to Gemvara, Inc. in February 2010. The company was founded in 2006 and is based in Boston, Massachusetts. As of April 27, 2016, Gemvara, Inc. operates as a subsidiary of Richline Group, Inc.

Liquidia Technologies

Series C in 2010
Liquidia Technologies is a late-stage clinical biopharmaceutical company based in Morrisville, North Carolina, that specializes in the development and commercialization of human therapeutics. The company utilizes its proprietary PRINT technology, a particle engineering platform that allows for the precise production of uniform drug particles, aimed at improving the safety, efficacy, and performance of various therapies. Liquidia is currently advancing two key product candidates: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for addressing local post-operative pain. In addition to its internal pipeline, Liquidia collaborates with leading pharmaceutical companies to leverage its PRINT technology across multiple therapeutic areas and drug types. The company also offers strategy and commercialization services for rare disease pharmaceutical products, including a generic formulation of treprostinil for pulmonary arterial hypertension. Founded in 2004, Liquidia Technologies continues to focus on transforming patient care through innovative therapeutic solutions.

Orthocon

Venture Round in 2009
ORTHOCON is a medical therapeutics company developing innovative absorbable products for orthopaedic and spine surgeries.

Chimerix

Series E in 2009
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, dedicated to developing innovative antiviral therapeutics for patients with serious diseases, including cancer and those undergoing transplant procedures. The company’s lead candidate, CMX001, targets life-threatening double-stranded DNA viral infections and has demonstrated antiviral activity in clinical studies involving immunocompromised patients. Ongoing research includes a Phase 2 study for preventing cytomegalovirus in stem cell transplant recipients and other studies addressing adenovirus and various herpes viruses. Chimerix is also developing CMX157, a nucleoside analogue aimed at treating HIV and hepatitis B, which has shown promising results in early trials. Additionally, the company is working on dociparstat sodium, a compound intended to inhibit key proteins linked to acute myeloid leukemia, and brincidofovir, an antiviral candidate for smallpox. Chimerix holds various licensing agreements to advance its research and has received substantial federal funding to support its initiatives in public health and medical countermeasures.

VaxInnate

Series D in 2009
VaxInnate is a vaccine company that focuses on developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. It specializes in the fields of healthcare, health diagnostics, and biotechnology. It was founded in 2002 and headquartered in Cranbury, New Jersey.

Peer39

Series C in 2009
Peer39 Tech, LLC specializes in AI-powered solutions for contextual targeting, fraud detection, and reporting. Utilizing natural language processing and machine learning, the company's platform analyzes web pages to provide a comprehensive suite of page-level intelligence products compatible with various demand-side platforms. Key offerings include intelligent page-level analysis, a keyword suggestion engine, category availability, and custom category automation, all designed to enhance advertisers' media investments and improve campaign insights. Founded in 2006 and based in New York, Peer39 has pioneered non-cookie-based data solutions, focusing on semantic contextual categories, brand safety, and page quality. The company has established itself as a leading provider of scalable and reliable data points, enabling brands and advertisers to optimize their digital media performance effectively.

Marinus Pharmaceuticals

Series B in 2009
Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings. The company was founded in 2003 and is based in Branford, Connecticut.

OpenSky

Series A in 2009
OpenSky OpenSky is a social platform that makes commerce more instant, open and connected. Founded by [John Caplan](http://www.crunchbase.com/person/john-caplan) and [Kevin Ambrosini](http://www.crunchbase.com/person/kevin-ambrosini-2), OpenSky has been named one of The World’s 50 Most Innovative Companies (alongside Apple, Facebook, Google, Amazon, Twitter, Square, Airbnb, Dropbox and Kickstarter) by Fast Company and one of America's Most Promising Companies by Forbes.